Unique ID issued by UMIN | UMIN000029941 |
---|---|
Receipt number | R000034025 |
Scientific Title | Continuity of home-based cardiac rehabilitation using remotely controlled cycling exercise system in retired elderly patients with heart failure: A pilot study |
Date of disclosure of the study information | 2017/11/20 |
Last modified on | 2020/04/07 16:56:03 |
Continuity of home-based cardiac rehabilitation using remotely controlled cycling exercise system in retired elderly patients with heart failure: A pilot study
Home-based cardiac rehabilitation using remotely controlled cycling exercise system
Continuity of home-based cardiac rehabilitation using remotely controlled cycling exercise system in retired elderly patients with heart failure: A pilot study
Home-based cardiac rehabilitation using remotely controlled cycling exercise system
Japan |
heart failure
Cardiology |
Others
NO
To investigate feasibility, safety and compliance of remotely supervised home-based cardiac rehabilitation in retired elderly patients with heart failure
Safety,Efficacy
Exploratory
Pragmatic
Phase I
Feasibility, safety and compliance of home-based cardiac rehabilitation using remotely controlled exercise system
Change in exercise tolerance such as peak VO2 and results of 6 minutes walk test after home-based cardiac rehabilitation
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Other |
remotely supervised home-based exercise
65 | years-old | <= |
Not applicable |
Male and Female
1.HF patients who were diagnosed as HF according to the guideline from European Society of Cardiology 2016
2.patients who are recommended to home-based exercise
3.patients who can not or do not want to visit center-based cardiac rehabilitation
4.Over 65 years old
5.patients who do not have regular job
1.patients who can not push pedals of cycling system due to other diseases or pain
2.patients who can participate center-based cardiac rehabilitation more than two sessions a week
3.patients who experienced decrease in blood pressure, fetal arrhythmia or other adverse events (eg. chest pain, dyspnea, syncope, vertigo, dizziness, leg pain, cyanosis, pallor, cold sweat, ataxia, hypotension, hypertension)
4.AMI patients within 3 months after onset, severe aortic stenosis, end-stage HF, end-stage renal failure (estimated GFR <20 ml/min/1.73m2), other end-stage disease
5.patients with residual myocardial ischemia
6.patients who have a risk for HF worsening due to exercise
7.post implantation of pacemaker or left ventricular assist device
8.dementia
9.patients living alone
10.patients without consent
11.patients who are not considered to be appropriate by attending physician
10
1st name | |
Middle name | |
Last name | Yasushi Sakata |
Osaka University Hospital
Department of Cardiovascular Medicine
2-15 Yamada-oka, Suita city, Osaka
06-6879-5111
yasushisk@cardiology.med.osaka-u.ac.jp
1st name | |
Middle name | |
Last name | Tatsunori Taniguchi |
Osaka University Graduate School of Medicine
Department of Biodesign for Healthcare Innovation
1-3 Yamada-oka, Suita city, Osaka
06-6105-5249
taniguch@cardiology.med.osaka-u.ac.jp
Osaka University Hospital
Osaka University
Other
NO
2017 | Year | 11 | Month | 20 | Day |
Unpublished
Completed
2017 | Year | 11 | Month | 15 | Day |
2017 | Year | 12 | Month | 28 | Day |
2018 | Year | 01 | Month | 01 | Day |
2018 | Year | 08 | Month | 31 | Day |
2018 | Year | 10 | Month | 31 | Day |
2017 | Year | 11 | Month | 12 | Day |
2020 | Year | 04 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034025